JP Morgan Chase
TENX icon

JP Morgan Chase’s Tenax Therapeutics TENX Stock Holding History

JP Morgan Chase’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
10,511
+1,093
+12% +$14K ﹤0.01% 5802
2026
Q1 		$132K Buy
9,418
+8,516
+944% +$115K ﹤0.01% 5690
2025
Q4 		$11K Buy
+902
New +$7.84K ﹤0.01% 6644

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

JP Morgan Chase's TENX Position: Q2 2026 in Review

JP Morgan Chase increased its Tenax Therapeutics (TENX) stake by 12% in Q2 2026, buying an estimated $14K and bringing the position to 10,511 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #5802.

JP Morgan Chase first reported a position in TENX in Q4 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • JP Morgan Chase held 10,511 shares of Tenax Therapeutics worth $142K as of Q2 2026.
  • JP Morgan Chase bought 1,093 Tenax Therapeutics shares in Q2 2026, an estimated $14K.
  • Tenax Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5802 holding.
  • JP Morgan Chase first reported a position in Tenax Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.